Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases

Cardiac involvement is a major prognostic determinant in patients with primary AL amyloidosis. The clinical results of standard therapeutic approaches are suboptimal. It has been recently shown that bortezomib, an inhibitor of the proteasome, can induce rapid favourable responses in AL amyloidosis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigrelli, Santi, Curciarello, Giuseppe, Ballo, Piercarlo, Michelassi, Stefano, Pizzarelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970246/
https://www.ncbi.nlm.nih.gov/pubmed/24715916
http://dx.doi.org/10.1155/2014/627474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970246/
https://www.ncbi.nlm.nih.gov/pubmed/24715916
http://dx.doi.org/10.1155/2014/627474

Ejemplares similares